112

Drugs
Sub Categories on Drugs
Latest Articles
Upadacitinib found to improve ulcerative colitis outcomes at 12 months

Upadacitinib found to improve ulcerative colitis outcomes at 12 months

by Elana GotkineFor patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months compared with tofacitinib, according to a studypublished&nbs

Upadacitinib found to improve ulcerative colitis outcomes at 12 months

by Elana GotkineFor patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months compared with tofacitinib, according to a studypublished&nbs
Team offers an open solution to improving research reproducibility

Team offers an open solution to improving research reproducibility

byMcGill UniversityLab work. Credit: The Neuro (Montreal Neurological Institute-Hospital)Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McG

Team offers an open solution to improving research reproducibility

byMcGill UniversityLab work. Credit: The Neuro (Montreal Neurological Institute-Hospital)Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McG
FDA expands approval of Vtama to include atopic dermatitis

FDA expands approval of Vtama to include atopic dermatitis

FDA expands approval of Vtama to include atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the

FDA expands approval of Vtama to include atopic dermatitis

FDA expands approval of Vtama to include atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the
GLP-1 Zepbound is approved as first drug for sleep apnea

GLP-1 Zepbound is approved as first drug for sleep apnea

by India EdwardsThe U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound.In a n

GLP-1 Zepbound is approved as first drug for sleep apnea

by India EdwardsThe U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound.In a n